Introduction have shown that E2F-1 overexpression is sufficient to induce DNA replication (Johnson et al., 1993; Qin et al., E2F proteins and DP proteins comprise two families of 1994; Shan and Kowalik et al., 1995) and transcription factors that form heterodimeric complexes that overexpression of dominant negative E2F mutants and confer cell cycle-specific expression to promoters inhibits cell cycle progression from G1 to S phase (Docontaining E2F-binding sites. The timing of E2F-medibrowolski et al., 1994) . Furthermore, studies in Drosophated transcription is regulated through several mechaila where only a single E2F has been identified (Dynlacht nisms. E2F-mediated transcription is repressed through et al., 1994a; Ohtani and Nevins, 1994) have demona physical association of E2F/DP heterodimers with prostrated that dE2F is required for entry into S phase teins of the retinoblastoma family (pRB, p107, or p130 (Duronio et al., 1995) . These studies suggest that E2F/ collectively referred to as the "pocket" proteins). Cyclin-DP transcriptional activity is rate-limiting for transition dependent kinase-mediated phosphorylation (Sherr, from G1 into S phase. Overexpression of E2F-1 or E2F-1994) or DNA tumor virus antigen binding 1/DP-1 cooperates with activated ras in fibroblast transinactivates the pocket proteins, leading to dissociation formation assays, and these transformed cells form tuof the pocket protein/E2F/DP complexes, and subsemors in nude mice (Johnson et al., 1994a ; Singh et al., quent activation of E2F-dependent transcription. Addi-1994; Jooss et al., 1995; Xu et al., 1995) , demonstrating tionally, E2F-mediated transcription is stimulated by an that E2F-1 can be oncogenic. Apart from the role of E2F-regulatory loop that amplifies the expression of the E2F-1 in stimulating proliferation, overexpression of E2F genes themselves (Hsiao et al., 1994; E2F-1 in some tissue culture cells can induce apoptosis Neuman et al., 1994) . Finally, E2F-mediated that is p53-dependent (Qin et al., 1994 ; Shan and Lee, transcription is attenuated late in S phase by cyclin-1994; Wu and Levine, 1994; Kowalik et al., 1995) . Overexdependent kinase phosphorylation of the E2F/DP heterpression of E2F-1 may induce apoptosis by regulating odimer, which results in the loss of DNA-binding activity (Dynlacht et al., 1994b; Krek et al., 1994; Xu et al., 1994) .
genes important for cell survival or perhaps by driving cells into S phase at an inappropriate time, which may all of exon 3 in the E2F-1 locus were replaced by the neo R gene in an antisense orientation ( Figure 1A ). This induce apoptosis.
Similar suggestions for the function of E2Fs in regulatdeletion removes amino acid residues 89-186 of mouse E2F-1 (Li et al., 1994 ; A. Talis and K. Helin, unpublished ing proliferation can be inferred from mutations in regulatory proteins upstream of E2F/DP function. Rb ϩ/Ϫ mice data), which correspond to amino acid residues 95-191 of human E2F-1. Exons 2 and 3 encode residues that develop pituitary and thyroid tumors (Jacks et al., 1992; Hu et al., 1994; Williams et al., 1994) . Cyclin D overexare known to be critical for cyclin A/cdk2 association and DNA binding, respectively (Helin et al., 1992 ; Kaelin pression in the mammary epithelium of transgenic mice produces mammary adenocarcinomas (Wang et al., et al., 1992; Shan et al., 1992; Dynlacht et al., 1994b; Krek et al., 1994; Xu et al., 1994) . Following electropora-1994). The frequent isolation of mutations in the genes encoding pRB, cyclin D, cdk4, or the cyclin-dependent tion and double drug selection of embryonic stem cell clones, Southern analysis revealed that homologous rekinase inhibitor p16 from human tumors reinforces the importance of the pRB pathway in negative growth concombination had occurred at the E2F-1 locus at high frequency (1/3 doubly resistant G418 R /gancyclovir R trol (Hunter, 1994; Kamb, 1995; Weinberg, 1995; Wolfel et al., 1995) . Taken together, these data strongly suggest clones or 1/17 singly resistant G418 R clones). Two E2F-1 heterozygous (ϩ/Ϫ) clones were used to produce that E2F/DP function may be a major target for pRBmediated growth suppression. These data have led to male chimaeras that transmitted the mutated E2F-1 allele through the germline to 50% of their agouti 129 ϫ a widely accepted model that E2F/DP activity promotes cell-cycle progression, and that pocket proteins sup-C57BL/6 offspring. F1 E2F-1 ϩ/Ϫ males and females were then interbred to produce F2 litters. Genotyping by press growth by repressing E2F/DP-mediated transactivation La Thangue, 1994; Muller, 1995;  Southern analysis ( Figure 1B ) or by genomic polymerase chain reaction (PCR; Figure 1C ) demonstrated that Weinberg, 1995) .
In addition to suppressing growth, pRB also appears E2F-1 homozygous (Ϫ/Ϫ) mutants, heterozygotes (ϩ/Ϫ), and wild-type animals were produced at the expected to inhibit apoptosis and facilitate differentiation, suggesting that E2F/DP complexes may participate in these ratio of 1:2:1. Since the E2F-1 Ϫ/Ϫ animals were viable, we next conprocesses as well. Rb Ϫ/Ϫ mouse embryos die between E14 and E16 of gestation, with increased levels of firmed that the E2F-1 protein was indeed absent. Owing to the extremely low levels of endogenous E2F-1 expresapoptosis in the central nervous system and fetal liver, and display incomplete erythropoiesis (Clarke et al., sion in wild type and E2F-1 ϩ/Ϫ asynchronously growing embryonic fibroblasts, the induction of higher levels of 1992; Jacks et al., 1992; Lee et al., 1992 Lee et al., , 1994 . Neuronal differentiation correlates with elevated levels of pRB in E2F-1 upon serum restimulation was compared between E2F-1 Ϫ/Ϫ and E2F-1 ϩ/Ϫ fibroblasts. Fibroblasts embryonic carcinoma cells (Slack et al., 1993) and is impaired in Rb Ϫ/Ϫ embryos , and myofrom E2F-1 Ϫ/Ϫ and E2F-1 ϩ/Ϫ embryos (E12.5) were synchronized by serum starvation and restimulated with tubes from pRB-negative cells are able to reenter the cell cycle (Gu et al., 1993; Schneider et al., 1994) . These serum for 18-20 hr to induce E2F-1 expression. E2F-1 levels in the resultant lysates were monitored by immudata underscore the delicate balance that pRB may help maintain between proliferation, apoptosis, and differennoprecipitation, then Western analysis with anti-E2F-1 antibodies ( Figure 1D ; all E2F-1 antibody reagents were tiation.
To assess the role of a single E2F in normal growth kindly provided by K. Helin). Either a monoclonal anti-E2F-1 antibody (KH129) or a polyclonal anti-E2F peptide and development and to test whether E2F-1 has a critical function in the regulation of proliferation, apoptosis, serum (anti-RBP3; Helin et al., 1992) was used for immunoprecipitation, followed by Western blotting with a pool and/or differentiation in vivo, we have inactivated the E2F-1 locus in mice by homologous recombination.
of two anti-E2F-1 specific monoclonal antibodies (KH22 and KH102). E2F-1 was detected with both antibodies Mice lacking E2F-1 are viable, yet several tissues are sensitive to the absence of E2F-1. Surprisingly however, in lysates from E2F-1 ϩ/Ϫ cells, but not in E2F-1 Ϫ/Ϫ cell lysates. Both the polyclonal and monoclonal antithe loss of E2F-1 also predisposes many of the homozygous E2F-1 Ϫ/Ϫ mutants to develop tumors. These E2F-1 antibodies recognize C-terminal epitopes of E2F-1 (Helin et al., 1992; K. Helin, unpublished data) . data strongly suggest that the working model in which Thus, the absence of a signal in E2F-1 Ϫ/Ϫ lysates strongly E2F-1 functions only to drive cell proliferation is incomsuggests that a C-terminal fragment of E2F-1 is not plete. In addition to promoting proliferation in some tisexpressed. Conceivably, an N-terminal fragment of sues, E2F-1 must act in some manner to suppress prolif-E2F-1 (amino acid residues 1-88) could be expressed; eration in other tissues. Thus E2F-1 is a previously however, since stop codons were introduced into the unrecognized tumor-suppressor protein. This illustrates altered exon 2, this fragment would lack the DNA-binda novel situation in which E2F-1 can act as an oncogene ing, heterodimerization, and pRB-binding domains of in some settings and as a tumor suppressor in others.
E2F-1. Thus, the viability of E2F-1 Ϫ/Ϫ animals occurred in the absence of a functional E2F-1 protein.
Results
E2F-1 Ϫ/Ϫ females and males examined at 2.5 months of age showed no gross anatomical or overt histological Inactivation of the E2F-1 Locus abnormalities. However, three abnormalities became To inactivate the E2F-1 locus by homologous recombiobvious with increasing age in the E2F-1 Ϫ/Ϫ animals. nation (Mansour et al., 1988; Capecchi, 1989) , we conThese include testicular atrophy, exocrine gland dysplasia, and the development of tumors and are discussed structed a targeting vector in which most of exon 2 and animals were viable and appeared at the expected frequency of 25%. After EcoRI digestion, hybridization with a 3Јprobe detects a 9.0 Kbp wild-type allele and a 9.8 Kbp mutant allele. (C) A genomic PCR assay was performed to genotype all progeny. Separate PCR reactions with either the E2F-1 exon 3 primer (L26) or the neo R gene primer (L28) and an intron primer (L31) were used to detect the wildtype allele (392 bp) or the mutant allele (167 bp), respectively. PCR primer positions are indicated in (A). (D) Immunoprecipitation-Western analysis for E2F-1. Lysates from serum-starved and restimulated 12.5-day-old mouse embryo fibroblasts were immunoprecipitated with either monoclonal (KH129) or polyclonal (anti-RBP3 peptide) antibody reagents for E2F-1 or control reagents (PAb419 or normal rabbit serum). Western blotting with two anti-E2F-1 monoclonals that recognize unique C-terminal epitopes of E2F-1 (KH22 and KH102) detected E2F-1 only in (ϩ/Ϫ) lysates. Recombinant mouse E2F-1 was used as a control for Western blotting (last lane).
in detail below. Other E2F-1 Ϫ/Ϫ tissues were examined per cross-section ( Figure 2C , right image). Interestingly, the number of Leydig cells did not appear to decrease and showed no change or only small sporadic differences.
with age and in some animals appeared to increase in number. Although the testes from E2F-1 Ϫ/Ϫ animals experiencing the most extreme atrophy appeared to Testicular Atrophy Both E2F-1 Ϫ/Ϫ males and females were fertile. However, contain many more Leydig cells, the apparent increase may have been due to the overall reduction in testicuall males autopsied between 9 and 15 months of age displayed testicular atrophy (Figure 2A ). The average lar size. Testicular atrophy as judged by average testicular testis weight for E2F-1 Ϫ/Ϫ males (52 Ϯ 20 mg) was 44% of the average testis weight for wild-type males (118 Ϯ weight reduction occurred in 27/27 autopsied E2F-1 Ϫ/Ϫ males and occurred in 1/11 of autopsied wild-type males 28 mg). In the most extreme cases, testis weight for E2F-1 Ϫ/Ϫ males was 10% of testis weight for wild-type by 15 months of age. Testicular atrophy has been observed in 11% of C57BL/6 mice (Bronson, 1990) , while males. Testicular atrophy had occurred as assessed by bilateral testicular weight reduction ( Figure 2B ) and testicular teratocarcinomas, rather than atrophy, occur frequently in 129 mice (Stevens, 1973) . The degeneration by histological appearance ( Figure 2C) . Histologically, the testes in 2.5-month-old E2F-1 Ϫ/Ϫ males appeared of the seminiferous tubules in the presence of Leydig cells was unexpected, since the testosterone produchealthy with numerous seminiferous tubules producing abundant sperm (data not shown), which is consistent tion from Leydig cells is considered to be a critical stromal signal necessary for productive spermatogenesis with the fertility of young E2F-1 Ϫ/Ϫ males. The only apparent histological difference in the testes of young E2F- (Russell, 1990) . Testicular atrophy in the E2F-1 Ϫ/Ϫ animals may have occurred because of a pituitary or testic-1 Ϫ/Ϫ males relative to that of young wild-type males was the presence of more interstitial cells (Leydig cells) beular hormonal defect or perhaps a refractory state of the seminiferous tubules to testosterone. Since spermatween the seminiferous tubules. By 9 months and becoming more evident in 12-month-old E2F-1 Ϫ/Ϫ males, togenesis in rodents must decrease by 90% to affect the number of progeny produced per litter (Russell, 1990) , the testes contained empty and degenerated seminiferous tubules. The number of empty tubules ranged from many of the E2F-1 Ϫ/Ϫ males by 9-12 months of age were most likely still fertile. several ( Figure 2C , middle image) to almost all tubules 
Exocrine Tissue Abnormalities
a role in maintaining normal nuclear structure in this All of the E2F-1 Ϫ/Ϫ mice had submaxillary and parotid tissue as well. salivary glands that were histologically abnormal. In both Despite the changes in the salivary glands and panof these tissues, cell nuclei were abnormally large and creas of E2F-1 Ϫ/Ϫ animals, body weights measured at swollen, and many cells were binucleate. The submaxil-6.7 and 8.7 months of age were not perceptibly different lary salivary gland is a mixed seromucous gland, which from those of wild-type littermates (data not shown). concentrates salts and produces lubricating glycoproHowever, between 12 and 15 months of age, a number teins and lysozyme. In the submaxillary glands of E2F-of autopsied E2F-1 Ϫ/Ϫ animals lost large amounts of 1 Ϫ/Ϫ animals, the mucous cells contained irregular, large weight, corresponding in some males to as much as nuclei ( Figure 3A ), while the serous cells were normal.
30%-40% of their weight at 8.7 months. Many of these The abundance of mucous acini compared to serous autopsied animals had no obvious abnormalities other acini within the submaxillary glands of E2F-1 Ϫ/Ϫ animals than exocrine gland deterioration and fatty changes in was low relative to that of wild-type animals. This dethe liver that often accompany drastic weight loss. crease occurred despite an increase in the size of individual mucous cells ( Figure 3A ). Interestingly, although
Tumor Formation in E2F-1 Ϫ/Ϫ Animals the mucous cells of the submaxillary gland were abnorBetween 8 and 18 months of age, many E2F-1 Ϫ/Ϫ animal in E2F-1 Ϫ/Ϫ animals, mucous cells of the sublingual mals developed tumors (Table 1) . Tumors observed insalivary gland were normal. In the parotid salivary gland, clude reproductive tract sarcomas, lung tumors, lymwhich produces amylase for the digestion of starch, phomas, and numerous other tumor types that were cells also contained abnormally large nuclei and often found at a lower frequency. E2F-1 Ϫ/Ϫ females and males were binucleate ( Figure 3B) . Likewise, the exappeared to be comparably susceptible to tumor formaorbital lacrimal gland of E2F-1 Ϫ/Ϫ animals contained abtion. A total of 35 tumors were observed out of 102 normally large nuclei (data not shown). Histological abautopsied E2F-1 Ϫ/Ϫ animals. There are an additional 80 normalities in the salivary glands became even more surviving E2F-1 Ϫ/Ϫ animals of this age cohort (originally pronounced in older E2F-1 Ϫ/Ϫ animals, and the overall 182 animals). The expected total tumor incidence for size of the salivary gland complex decreased with age wild-type animals of various genetic backgrounds is only (data not shown).
0%-2% by 12 months and rises to 10% by 18 months Other exocrine tissues also appeared sensitive to the (Bronson and Lipman, 1991) . Since 34% (35/102) of auloss of E2F-1. Abnormally large nuclei or nuclei doubled topsied E2F-1 Ϫ/Ϫ animals developed tumors mostly in number were observed in the exocrine portion of the within 15 months (Table 1) , tumor development was ac-E2F-1 Ϫ/Ϫ pancreas ( Figure 3C ). The zymogen granule celerated in the absence of E2F-1. This estimated tumor content in the pancreas was low and the gross anatomiincidence of 34% is higher than the true tumor incidence, cal appearance of the pancreas deteriorated in older because in most cases (75%) sick E2F-1 Ϫ/Ϫ animals E2F-1 Ϫ/Ϫ animals relative to that observed in wild-type were chosen for autopsy. If no occult tumors are found animals. The presence of greatly enlarged nuclei in the in the remaining 80 E2F-1 Ϫ/Ϫ animals, then the tumor exocrine tissues of E2F-1 Ϫ/Ϫ animals suggests that incidence would be 19% (35/182). The actual tumor inci-E2F-1 helps maintain the normal nuclear structure and dence lies between these two values (19% and 34%) possibly the correct DNA content within these tissues.
for animals at 18 months of age. Since nuclear size variation to a lesser extent also occurred in the livers of E2F-1 Ϫ/Ϫ animals, E2F-1 may have Since one-third of the tumors isolated from E2F-1
heterozygosity at the E2F-1 locus in one of the lung tumors was not demonstrable by either Southern analysis or scrape PCR from histological sections. This may be due to the presence of subtle mutations at the E2F-1 locus that escaped detection or the presence of normal tissue within the examined tumor specimen.
Reproductive Tract Sarcoma
Eleven E2F-1 Ϫ/Ϫ virgin animals (8 females and 3 males) between 12.7 and 16.5 (mean of 13.6; Table 1) months of age developed aggressive sarcomas that appeared grossly as large yellow/white masses in the reproductive tracts. These tumors often attained a remarkable size in the uterine horns (from 0.25 g to 5 g; Figure 4A , right image) and sometimes in the ovaries of females, as well as in the epididymis of males ( Figure 4C , right image). Reproductive tract sarcomas represent one-third of the tumors found in the E2F-1 Ϫ/Ϫ animals. In over 1000 mice (Rb ϩ/Ϫ or P53 Ϫ/Ϫ or Nf1 ϩ/Ϫ or control mice) produced with the same hybrid 129 ϫ C57BL/6 genetic background used in this study, no reproductive tract sarcoma has been observed (Jacks et al., 1992 (Jacks et al., , 1994 Williams et al., 1994) . In addition, this sarcoma was not seen in studies following 1134 or 1577 mice of various genetic background for 24-30 months (Bronson and Lipman, 1991) .
Histologically, the cellular composition of the sarcoma appeared quite uniform and nonglandular in the uterine horns of females ( Figure 4C ) and epididymis of males ( Figure 4D ). Tumor cells were densely packed at these sites and occasionally small capillaries could be seen. The most likely histological classification of the reproductive tract sarcoma in females is either endometrial stromal sarcoma (Dr. C. Fletcher, personal communication) or histiocytic sarcoma, between which a histologi- population and commonly present in the liver and spleen; however in humans, histiocytic sarcoma is exanimals were reproductive tract sarcomas (see betremely rare. Furthermore, epididymal tumors in mice low)-an extremely rare tumor in the 129 ϫ C57BL/6 and humans are very infrequent (Turusov and Mohr, hybrid genetic background used in this study-the ele-1994). Also, the epididymal tumor in E2F-1 Ϫ/Ϫ mice vation of the incidence of this tumor is striking. The grows between the ducts carrying maturing sperm, in tumor profile of E2F-1 Ϫ/Ϫ mutants is unique, since the a space normally occupied by smooth muscle and conmost common tumor is lymphoma for the C57BL/6 nective tissue without a stromal cell equivalent. mouse strain (Bronson, 1990) and testicular teratocarciIn both females and males, the metastatic potential noma for the 129 mouse strain (Stevens, 1973) .
of these tumors was quite high and could be followed Several E2F-1 ϩ/Ϫ animals also developed tumors (Taeasily by the tumor's canary yellow color ( Figures 4E  ble 1 ). Four E2F-1 ϩ/Ϫ females developed reproductive and 4G). Six of the 11 E2F-1 Ϫ/Ϫ animals with this tumor tract sarcomas and 3 E2F-1 ϩ/Ϫ animals developed lung showed numerous metastases in more than 4 abdominal adenocarcinomas. The development of rare tumors alorgans, and all of these animals had metastases on the ready observed in the E2F-1 Ϫ/Ϫ animals and subsediaphragm and omentum (a membrane to which the quently in 7 E2F-1 ϩ/Ϫ animals suggested that loss of liver, spleen, and stomach are attached; Figure 4E ). Hisheterozygosity at the E2F-1 locus may have occurred tologically, the tumor cells were highly invasive, penetrating deep into the pancreas ( Figure 4F) , kidney, liver, in the tumors of the E2F-1 ϩ/Ϫ animals. However, loss of fat, and regional lymph nodes ( Figure 4H ). In 2 cases metastases were found in the lungs. While the majority of the metastases appeared histologically similar to the primary tumors in the uterine horns or epididymis, the metastases in fat or in lymph nodes ( Figure 4H ) contained cells with abundant cytoplasm and distinct borders, which simply may reflect the packing density possible in these tissues. Spontaneous tumor metastases of solid tumors in mice are rare (R. Bronson, unpublished observation), and thus, the ability of the E2F-1 Ϫ/Ϫ reproductive tract sarcomas to metastasize is noteworthy.
Lung Tumors
Seven of the autopsied E2F-1 Ϫ/Ϫ animals between 8.8 and 18 months of age developed lung tumors (up to 1.5 cm in diameter) that often occupied half of the thoracic cavity ( Figure 5A ; Table 1 ). These tumors were classified as highly invasive lung adenocarcinomas or generally as non-small-cell lung carcinomas. In most cases, the gross anatomical architecture of the several major lung lobes as well as the architecture of the smaller mediastinal lung lobes was deformed by the tumor growth. In other studies, only 1 lung adenocarcinoma was seen in over 1000 mice (Rb ϩ/Ϫ , p53
, Nf1 ϩ/Ϫ , or control mice) with the hybrid 129 x C57BL/6 genetic backgound used in this study (Jacks et al., 1992 (Jacks et al., , 1994 Williams et al., 1994) . Similarly, lung adenocarcinomas were not observed in 1134 mice of various genetic backgrounds followed over a 24 month period (Bronson and Lipman, 1991) .
Histologically, the normal lace-like alveolar space ( Figure 5B , upper image) was overtaken by the expanding tumor ( Figure 5B , lower image). From the same mutant animals, lung lobes which at first appeared grossly normal were later identified as containing smaller islands of tumor cells ( Figure 5B , middle image) that had most likely metastasized from the neighboring affected lung lobes. Smaller islands of tumor often were surrounded by numerous alveolar histiocytes. Less severe lung adenomas (1-2 mm) were commonly seen in Table 1 ) and also in wild type animals.
that occupied more than half the thoracic cavity (right). Lungs from a wild-type animal (left) are shown for comparison. fected animals displayed enlarged lymph nodes ( Figure  6A ), splenomegaly (from 0.1 g up to 1.0-4.3 g; Figure  young E2F-1 Ϫ/Ϫ animals, were not detected on periph-6B), anemia (hematocrits were reduced from 40%-45% eral T cells from young animals or on thymocytes from to 8%-15%), and glomerulonephritis of the kidneys older animals. Although lpr mice and gld mice, which (data not shown). This occurred in one wild-type female have naturally occurring mutations in Fas and the Fas as well. Although environmental factors may have influligand respectively, develop a lymphoproliferative state enced the development of lymphoproliferation, we exwith generalized lymph node enlargement, splenomegamined lymphocyte populations from wild-type and aly, and glomerular nephritis, Fas levels in E2F-1 Ϫ/Ϫ ani-E2F-1 Ϫ/Ϫ animals for possible differences. Fluoresencemals were not consistently affected (data not shown). activated cell sorter analysis of lymphocytes from thyLymphoproliferation may have been a preneoplastic mus, spleen, and lymph nodes of young and old animals condition in the E2F-1 Ϫ/Ϫ animals, since 8 E2F-1 Ϫ/Ϫ anidemonstrated that most B and T lymphocyte surface mals between 12 and 16.5 months of age developed markers were normal (data not shown). Moderate differlymphomas (Table 1) . Five of these E2F-1 Ϫ/Ϫ animals ences in the T-cell receptor-associated signaling molecule, CD3⑀, which were apparent on thymocytes from developed follicular center cell lymphomas in enlarged from the testicular atrophy and salivary gland dysplasia observed. Overt malformation is not observed even in normal E2F-1 Ϫ/Ϫ tissues from which tumors and hyperplasia develop. At the simplest level this must indicate that tissues such as the testis and salivary gland rely heavily on the correct function of E2F-1 and that this E2F-1 function cannot be replaced in all tissues by other cellular activities.
Lymphoproliferation and Lymphoma

Tissue and Temporal Specificity
Given the known capacity of E2F-1 to stimulate cellular proliferation and to act as an oncogene, we anticipated that one possible outcome from inactivating the E2F-1 locus might have been decreased proliferation. Another possible outcome might have been less apoptosis, in light of the capability of E2F-1 to induce apoptosis. Still another possibility is that inactivation of the E2F-1 locus might have compromised the ability of pRB to suppress proliferation, therefore leading to hyperproliferation. While examining the E2F-1 Ϫ/Ϫ mice, we were struck by the radically different cellular and tissue responses to the loss of E2F-1. In exocrine cells, we have detected abnormally large and doubled nuclei, which may have undergone DNA replication without cell division. In the testes of E2F-1 Ϫ/Ϫ mice, tissue atrophy correlates with loss of seminiferous tubules. In a subset of affected apoptosis that results in hyperproliferation. They also Scale bars are 5 mm.
observed that their older E2F-1 Ϫ/Ϫ mice undergo testicular atrophy. A single effector function of E2F-1 cannot explain the diverse outcomes seen in all of the affected mesenteric nodes (up to 1.5 cm in diameter; Figure 6C ). The incidence for lymphoma is 7.8% (8/102) of autopsied tissues, and thus eventually we must consider the potential functions of E2F-1 in each of these separate tissues. E2F-1 Ϫ/Ϫ animals. The expected frequency is 1.5% by 18 months in mice of various genetic backgrounds There are several possibilities as to why the defects observed in the E2F-1 Ϫ/Ϫ mutants show tissue and tem- (Bronson and Lipman, 1991) .
poral specificity. At a biochemical level, the different tissue specific responses to the loss of E2F-1 suggest Discussion three possible mechanisms: E2F-1 regulates different genes in different tissues; E2F-1 controls expression of E2F-1 Is Not Required for Viability or Normal Development the same genes differently in the various tissues, perhaps in combination with tissue specific factors; or tisThe normal development and the fertility of the E2F-1
Ϫ/Ϫ mice demonstrate that the function of E2F-1 is not sues respond differently to the same target genes regulated by E2F-1. Temporal changes in E2F-1-dependent required for either cell or animal survival. If E2F-1 is important for viability, then this E2F-1 function lost by gene regulation add another variable to these mechanisms. To begin to analyze why the affected tissues are inactivation of the E2F-1 locus must have been masked, perhaps by the continued action of other E2F family sensitive to the loss of E2F-1, it will be important to delineate the expression pattern for all E2F family memmembers. Eventually, the production of mice deficient for other E2F family members will allow us to test bers relative to one another and to identify the actual E2F-1 target genes in the affected tissues. whether the E2F family is essential. Despite the viability of E2F-1 Ϫ/Ϫ mice, specific tissues in all E2F-1 Ϫ/Ϫ mice An additional level of complexity comes from the realization that a transcriptional response mediated through were sensitive to the loss of E2F-1. Loss of E2F-1 does not induce grossly abnormal development, but rather E2F sites may be either activation or repression, depending on the promoter contexts in which the E2F sites in a subset of tissues leads to subtle aberrations that become increasingly more obvious with time, as evident lie (Weintraub et al., 1992) . Deletion or mutation of E2F sites within promoters can lead to decreases (i.e., DHFR growth suppressive properties. Interestingly, the E2F-1 gene on mouse chromosome 2 maps near the agouti A promoter) or increases (e.g. b-myb and E2F-1) in transcription (Blake and Azizkhan, 1989; Means et al., 1992;  locus that determines coat color (Li et al., 1994; K. Helin and N. Jenkins, unpublished data) . Since the agouti le- Lam and Watson, 1993; Hsiao et al., 1994; Johnson et al., 1994b; Neuman et al., 1994) . Decreases in transcription thal yellow allele, A y , is associated with spontaneous tumors and has a 120-170 kb deletion (Duhl et al., 1994;  following E2F site mutation correspond to the loss of E2F-dependent transactivation, while increases in tran- Michaud et al., 1994) , E2F-1 expression may be altered in mice carrying this rearranged A y allele. scription following E2F site mutation likely result from the loss of repression by pocket protein/E2F com-
The tissues affected by tumorigenesis also argue for specific differences in the response to the loss of plexes.
The dual nature of E2F sites to act positively or nega-E2F-1. As observed for testicular atrophy and exocrine gland dysplasia, tumor development occurs only in spetively may allow E2F-1 to perform vastly different tasks in vivo depending on the function of the target gene.
cific sites. The tissues that are common sites of E2F-1-mediated tumorigenesis must rely more heavily on First, consider E2F-1 as an activator. If E2F-1 transactivates target genes that stimulate cell cycle progression E2F-1 than other tissues. This same argument fits well with the observed tissue-specific development of tu-(e.g. cyclin E, other E2Fs) or prolong cell survival, then loss of E2F-1 may decrease the cycling cell population.
mors seen with inheritance of other tumor suppressor gene mutations. In contrast, if E2F-1 transactivates target genes that increase apoptosis (e.g. c-myc) or facilitate differentiation (possibly pRB itself), then loss of E2F-1 may in-A pRB/E2F-1 Tumor Suppressor Complex crease the cycling cell population. Alternatively, if we Tumor development in the E2F-1 Ϫ/Ϫ mice most likely consider pRB/E2F-1 as a repressor, then loss of E2F-1 results from the loss of pRB/E2F-1-mediated growth and the subsequent loss of pRB/E2F-1-mediated resuppression, which is consistent with the biochemical pression of target genes may lead to outcomes, which evidence for pRB/E2F-1 complex formation in vitro and are now opposite to those predicted for E2F-1 as an in vivo. Loss of growth suppression by the loss of a activator. In tumors, loss of E2F-1 may increase the pRB/E2F-1 complex strongly suggests that pRB/E2F-1 cycling cell population, which in combination with the actively represses key promoters by occupying E2F accumulation of additional mutations, results in maligsites. Recent work suggests that repression by pRB/ nancy. At this time however, there is no evidence for E2F DNA-bound complexes appears to block both E2F-either a cell-autonomous or non-cell-autonomous pathmediated transactivation and also transactivation mediway to atrophy or tumor development.
ated by other transcription factors (Weintraub et al., 1992 (Weintraub et al., , 1995 Flemington et al., 1993; Helin et al., 1993 ; E2F-1 Is a Tumor Suppressor Protein Adnane et al., 1995; Bremner et al., 1995; Qin et al. , The development of tumors in E2F-1 Ϫ/Ϫ animals strongly 1995; Sellers et al., 1995) . We propose that active represargues that E2F-1 is a previously unrecognized tumor sion by a pRB/E2F-1/DP tumor suppressor complex suppressor protein. The increased incidence of tumors bound to key promoters is lost in the E2F-1 Ϫ/Ϫ animals in E2F-1 Ϫ/Ϫ animals is impressive, especially considerand predisposes to tumor formation. ing the age at which tumors were detected and the size, Clearly, the loss of E2F-1 is not equivalent to the loss the invasiveness, and the high metastatic potential of of pRB, which in mice is lethal (Clarke et al., 1992 ; Jacks the tumors. The frequency of reproductive tract sarcoma et al., 1992; Lee et al., 1992) . Even the tumors seen in suggests that E2F-1 has a key growth suppressive role the E2F-1 Ϫ/Ϫ mice (Table 1) are distinct from the pituitary in the uterine horns of females and the epididymus of adenomas (Jacks et al., 1992) and thyroid tumors (Wilmales. However, the incidence and long latency for the liams et al., 1994) arising in Rb ϩ/Ϫ mice. Only one autopdevelopment of these tumors indicates that additional sied E2F-1 ϩ/Ϫ animal developed a pituitary adenoma. mutations are required. The extent of the metastasis While many of the E2F-1 Ϫ/Ϫ mice develop lung adenofrom the reproductive tract to numerous abdominal orcarcinomas, Rb ϩ/Ϫ mice develop only a low level of brongans suggests that E2F-1 normally may repress genes chial epithelium hyperplasia (Williams et al., 1994) . The that facilitate, or activate genes that inhibit, metastasis.
human tumors in which RB1 mutations are found comAlternatively, the reproductive tract sarcoma may be a monly, such as retinoblastomas, osteosarcomas, small highly metastatic tumor with or without the loss of cell lung carcinomas, and carcinomas of breast, blad-E2F-1.
der, and prostate (Riley et al., 1994; Weinberg, 1995) , Although no human disease has been mapped to also were not observed in the E2F-1 Ϫ/Ϫ mice. the chromosomal position of human E2F-1 at 20q11, We expected the E2F-1 Ϫ/Ϫ phenotype to differ from E2F-1 gene amplification with overexpression in an the Rb ϩ/Ϫ or Rb Ϫ/Ϫ phenotype in mice for several reasons. erythroleukemic cell line and translocation of the First, loss of pRB leads to the derepression of E2F-1, E2F-1 locus with very low E2F-1 expression in mono-E2F-2, and E2F-3 simultaneously, while loss of E2F-1 blastic cell lines have been identified (Saito et al., 1995) . may lead to derepression and loss of activation of E2F-These data suggest that abnormal changes in E2F-1 1-specific target genes. Secondly, pRB binds many difexpression may be involved in human tumor developferent transcription factors besides E2F (Riley et al., ment. Furthermore, the E2F-1 gene at 20q11 lies near 1994; Horowitz and Udvadia, 1996) and dysregulation of the pRB-related p107 gene at 20q11.2 (Saito et al., 1995) this is the first example of a gene product that is able to induce tumors either by overexpression of the wild-and represses genes required for proliferation, and E2F-1 is not required for viability or proliferation. There-
Autopsy and Histopathology
fore, gain-of-function and loss-of-function mutations Between 8 and 18 months, 102 E2F-1 Ϫ/Ϫ animals were autopsied.
promote proliferation and enhance tumorigenesis. Any Animals were autopsied in most cases (75%) because they had lost gene whose product can serve this dual role will likely weight and appeared in poor health or had a palpable abnormality.
be both an oncogene and tumor suppressor.
All tissues were examined from 83 E2F-1 Ϫ/Ϫ animals regardless of their pathologic status. Tissues were formalin fixed, dehydrated, and embedded in paraffin according to standard protocols. Sections Experimental Procedures (4-5 m) were stained with hematoxylin and eosin and examined microscopically.
Construction of a Targeting Vector
A 129 mouse genomic phage clone containing the E2F-1 gene was mapped to identify exon positions using the mouse E2F-1 cDNA Acknowledgments sequence (Li et al., 1994 ; A. Talis and K. Helin, unpublished data). A 5.9 Kbp SphI-XbaI genomic fragment ( Figure 1A) , containing 4
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